A high-throughput cidality screen for Mycobacterium tuberculosis

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Kaur, Parvinder ^a   Ghosh, Anirban ^b   Krishnamurthy, Ramya Vadageri ^c   Bhattacharjee, Deepa Gagwani ^a   Achar, Vijayashree ^a   Datta, Santanu ^c   Narayanan, Shridhar ^a   Anbarasu, Anand ^d   Ramaiah, Sudha ^d  

^a ASTRAZENECA   (United Kingdom)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c Gangagen Biotech Private Limited ^*  (India)

^d VIT UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERICIDE; COMPLEMENTARY RNA; ETHAMBUTOL; ISONIAZID; OFLOXACIN; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASSAY; BACTERICIDAL ACTIVITY; BIOSAFETY; CONTROLLED STUDY; DRUG DETERMINATION; DRUG SCREENING; GENE SILENCING; HIGH THROUGHPUT SCREENING; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; SPOT ASSAY; VALIDATION STUDY; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; PRECLINICAL STUDY; PROCEDURES; SAFETY; STANDARD; STANDARDS;

MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS;

ANTITUBERCULAR AGENTS; DRUG EVALUATION, PRECLINICAL; HIGH-THROUGHPUT SCREENING ASSAYS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; REFERENCE STANDARDS; SAFETY;

EID: 84923309000     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117577     Document Type: Article

References (19)

1. Global Tuberculosis Report (2013) World Health Organization: Geneva p1. Available: http://www.who. int/tb/publications/global-report/gtbr13-main-text.pdf?ua=1.
2. Wells WF (1934) On airborne infection II: Droplets and droplet nuclei. Am J Hyg 20:611-618.
3. Riley RL, Wells WF, Mills CC, Nyka W, Mclean RL (1957) Air Hygiene in tuberculosis: quantitative studies of infectivity and control in a pilot ward. Am Rev Tuberc and Pulm Dis 75:420-431. PMID: 13403171
4. Wedum AG, Kruse RH, Detrick F, Frederick MD (1969) Assessment of risk of human infection in the microbiological laboratory. Ft. Belvoir Defense Technical Information Center JUL 1969.
5. Zhang L, Schweizer L (2011) Building the bridge from drug discovery to clinical research using pathway approaches. International Drug Discovery April/May, 60-67.
6. Andries K, Verhasselt P, Guillemont JEG, Gohlmann HWH, Neefs JM, et al. (2005) Diarylquinoline, drug active on the ATP synthase of Mycobacterium tuberculosis. Science 307:223-227. PMID: 15591164
7. Beydon MH, Fournier A, Drugeault L, Becquart J (2000) Microbiological high throughput screening: an opportunity for the lead discovery process. J Biomol Screen 5(1):13-22. PMID: 10841596
8. Cooksey RC, Morlock GP, Beggs M, Crawford JT (1995) Bioluminescence method to evaluate antimicrobial agents against Mycobacterium avium. Antimicrob Agents Chemother 39:754-756. PMID: 7793886
9. Collins LA, Torrero MN, Franzblau SG (1998) Green fluorescent protein reporter microplate assay for high-throughput screening of compounds against Mycobacterium tuberculosis. Antimicrob Agents and Chemother 42(2):344-347.
10. Altaf M, Christopher HM, David SB, O'Toole R (2010) Evaluation of the Mycobacterium smegmatis and BCG models for the discovery of Mycobacterium tuberculosis inhibitors. Tuberculosis 90:333-337. doi: 10.1016/j.tube.2010.09.002 PMID: 20933470
11. Ruth McNerney Kambashi BS, Kinkese J, Tembwe R, Godfrey FP (2004) Development of a bacteriophage phage replication assay for diagnosis of pulmonary tuberculosis. J Clin Microbiol 42(5):2115-2120. doi: 10.1128/JCM.42.5.2115-2120 PMID: 15131178
12. Primm TP, Franzblau SG (2007) Recent advances in methodologies for the discovery of antimycobacterial drugs. Current Bioactive Compounds 3:1-7.
13. Gilchrist JE, Campbell JE, Donnelly CB, Peeler JT, Delaney JM (1973) Spiral plate method for bacterial determination. Applied Microbiology 25(2):244-252. PMID: 4632851
14. CLSI-Clinical and Laboratory Standards Institute (CLSI), Susceptibility testing of Mycobacteria, Nocardia, and other aerobic actinomycetes 940 West Valley Road, Suite 1400, Wayne, PA 19087 USA.
15. Davey H (2011) Life, death and in-between: meanings and methods in Microbiology. Applied and Environmental Microbiology 77(16):5571-5576. doi: 10.1128/AEM.00744-11 PMID: 21705550
16. Kaur P, Agarwal S, Datta S (2009) Delineating bacteriostatic and bactericidal targets in mycobacteria using IPTG inducible antisense expression. PLOS One 4 (6) e5923. doi: 10.1371/journal.pone.0005923 PMID: 19526063
17. Jagannathan V, Kaur P, Datta S (2010) Polyphosphate kinase from M. tuberculosis: an interconnect between the genetic and biochemical role. PLoS One 5(12):2143336.
18. Jayaram R, Gaonkar S, Kaur P, Suresh BL, Mahesh BN, et al. (2003) Pharmacokinetic-pharmacodynamic relationships for rifampicin in an aerosol infection model of tuberculosis. Antimicrob Agents and Chemother 47:2118-2124. PMID: 12821456
19. Sassetti CM, Boyd DH, Rubin EJ (2003) Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol 48(1):77-84. PMID: 12657046